According to Neuren Pharmaceuticals's latest financial reports the company has C$0.19 Billion in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $C$0.18 B | 382.85% |
2022-12-31 | $C$38.4 M | 5.89% |
2021-12-31 | $C$36.26 M | 52.86% |
2020-12-31 | $C$23.72 M | 87.38% |
2019-12-31 | $C$12.66 M | -46.51% |
2018-12-31 | $C$23.67 M | 47.39% |
2017-12-31 | $C$16.06 M | 296.39% |
2016-12-31 | $C$4.05 M | -72.16% |
2015-12-31 | $C$14.55 M | -19.67% |
2014-12-31 | $C$18.11 M | -21.65% |
2013-12-31 | $C$23.12 M | 252.95% |
2012-12-31 | $C$6.55 M | -33.54% |
2011-12-31 | $C$9.85 M | 174.8% |
2010-12-31 | $C$3.58 M | -48.34% |
2009-12-31 | $C$6.94 M | 45.29% |
2008-12-31 | $C$4.78 M | -27.41% |
2007-12-31 | $C$6.58 M | -55.56% |
2006-12-31 | $C$14.81 M | -45.9% |
2005-12-31 | $C$27.39 M | 236.24% |
2004-12-31 | $C$8.14 M | |
2003-12-31 | $N/A | |
2002-12-31 | $N/A |